305 related articles for article (PubMed ID: 16924473)
21. Lack of correlation between MSH3 immunohistochemistry and microsatellite analysis for the detection of elevated microsatellite alterations at selected tetranucleotide repeats (EMAST) in colorectal cancers.
Laycock A; Kang A; Ang S; Texler M; Bentel J
Hum Pathol; 2021 Dec; 118():9-17. PubMed ID: 34537247
[TBL] [Abstract][Full Text] [Related]
22. Elevated microsatellite alterations at selected tetranucleotides in early-stage colorectal cancers with and without high-frequency microsatellite instability: same, same but different?
Watson MM; Lea D; Rewcastle E; Hagland HR; Søreide K
Cancer Med; 2016 Jul; 5(7):1580-7. PubMed ID: 27061136
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the Three Customized MSI Panels to Improve the Detection of Microsatellite Instability in Gastric Cancer.
Park J; Shin S; Yoo HM; Lee SW; Kim JG
Clin Lab; 2017 Apr; 63(4):705-716. PubMed ID: 28397474
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of elevated microsatellite alterations at selected tetranucleotide repeats in pancreatic ductal adenocarcinoma.
Mori T; Hamaya Y; Uotani T; Yamade M; Iwaizumi M; Furuta T; Miyajima H; Osawa S; Sugimoto K
PLoS One; 2018; 13(12):e0208557. PubMed ID: 30532127
[TBL] [Abstract][Full Text] [Related]
25. Relationship of EMAST and microsatellite instability among patients with rectal cancer.
Devaraj B; Lee A; Cabrera BL; Miyai K; Luo L; Ramamoorthy S; Keku T; Sandler RS; McGuire KL; Carethers JM
J Gastrointest Surg; 2010 Oct; 14(10):1521-8. PubMed ID: 20844976
[TBL] [Abstract][Full Text] [Related]
26. Inflammation-Associated Microsatellite Alterations Caused by MSH3 Dysfunction Are Prevalent in Ulcerative Colitis and Increase With Neoplastic Advancement.
Munakata K; Koi M; Kitajima T; Tseng-Rogenski S; Uemura M; Matsuno H; Kawai K; Sekido Y; Mizushima T; Toiyama Y; Yamada T; Mano M; Mita E; Kusunoki M; Mori M; Carethers JM
Clin Transl Gastroenterol; 2019 Dec; 10(12):e00105. PubMed ID: 31789935
[TBL] [Abstract][Full Text] [Related]
27. MSI-L/EMAST is a predictive biomarker for metastasis in colorectal cancer patients.
Torshizi Esfahani A; Seyedna SY; Nazemalhosseini Mojarad E; Majd A; Asadzadeh Aghdaei H
J Cell Physiol; 2019 Aug; 234(8):13128-13136. PubMed ID: 30549036
[TBL] [Abstract][Full Text] [Related]
28. Promoter methylation and immunohistochemical expression of hMLH1 and hMSH2 in sporadic colorectal cancer: a study from India.
Malhotra P; Anwar M; Kochhar R; Ahmad S; Vaiphei K; Mahmood S
Tumour Biol; 2014 Apr; 35(4):3679-87. PubMed ID: 24317816
[TBL] [Abstract][Full Text] [Related]
29. Deciphering Elevated Microsatellite Alterations at Selected Tetra/Pentanucleotide Repeats, Microsatellite Instability, and Loss of Heterozygosity in Colorectal Cancers.
Wang Y; Vnencak-Jones CL; Cates JM; Shi C
J Mol Diagn; 2018 May; 20(3):366-372. PubMed ID: 29474982
[TBL] [Abstract][Full Text] [Related]
30. EMAST is a Form of Microsatellite Instability That is Initiated by Inflammation and Modulates Colorectal Cancer Progression.
Carethers JM; Koi M; Tseng-Rogenski SS
Genes (Basel); 2015 Mar; 6(2):185-205. PubMed ID: 25836926
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of loss of expression of DNA mismatch repair proteins in primary epithelial ovarian tumors.
Lu FI; Gilks CB; Mulligan AM; Ryan P; Allo G; Sy K; Shaw PA; Pollett A; Clarke BA
Int J Gynecol Pathol; 2012 Nov; 31(6):524-31. PubMed ID: 23018216
[TBL] [Abstract][Full Text] [Related]
32. Elevated microsatellite instability at selected tetranucleotide (EMAST) repeats in gastric cancer: a distinct microsatellite instability type with potential clinical impact?
Herz AL; Wisser S; Kohlruss M; Slotta-Huspenina J; Jesinghaus M; Grosser B; Steiger K; Novotny A; Hapfelmeier A; Schmidt T; Gaida MM; Weichert W; Keller G
J Pathol Clin Res; 2022 May; 8(3):233-244. PubMed ID: 35099128
[TBL] [Abstract][Full Text] [Related]
33. Elevated Microsatellite Alterations at Selected Tetranucleotides (EMAST) in Colorectal Cancer is Associated with an Elderly, Frail Phenotype and Improved Recurrence-Free Survival.
Watson MM; Kanani A; Lea D; Khajavi RB; Søreide JA; Kørner H; Hagland HR; Søreide K
Ann Surg Oncol; 2020 Apr; 27(4):1058-1067. PubMed ID: 31686344
[TBL] [Abstract][Full Text] [Related]
34. No evidence of EMAST in whole genome sequencing data from 248 colorectal cancers.
Kondelin J; Martin S; Katainen R; Renkonen-Sinisalo L; Lepistö A; Koskensalo S; Böhm J; Mecklin JP; Cajuso T; Hänninen UA; Välimäki N; Ravantti J; Rajamäki K; Palin K; Aaltonen LA
Genes Chromosomes Cancer; 2021 Jul; 60(7):463-473. PubMed ID: 33527622
[TBL] [Abstract][Full Text] [Related]
35. Interleukin 6 alters localization of hMSH3, leading to DNA mismatch repair defects in colorectal cancer cells.
Tseng-Rogenski SS; Hamaya Y; Choi DY; Carethers JM
Gastroenterology; 2015 Mar; 148(3):579-89. PubMed ID: 25461668
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and implications of elevated microsatellite alterations at selected tetranucleotides in cancer.
Watson MM; Berg M; Søreide K
Br J Cancer; 2014 Aug; 111(5):823-7. PubMed ID: 24691426
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapy induced microsatellite instability and loss of heterozygosity in chromosomes 2, 5, 10, and 17 in solid tumor patients.
Kamat N; Khidhir MA; Hussain S; Alashari MM; Rannug U
Cancer Cell Int; 2014; 14(1):118. PubMed ID: 25493073
[TBL] [Abstract][Full Text] [Related]
38. Modulation of mismatch repair and genomic stability by miR-155.
Valeri N; Gasparini P; Fabbri M; Braconi C; Veronese A; Lovat F; Adair B; Vannini I; Fanini F; Bottoni A; Costinean S; Sandhu SK; Nuovo GJ; Alder H; Gafa R; Calore F; Ferracin M; Lanza G; Volinia S; Negrini M; McIlhatton MA; Amadori D; Fishel R; Croce CM
Proc Natl Acad Sci U S A; 2010 Apr; 107(15):6982-7. PubMed ID: 20351277
[TBL] [Abstract][Full Text] [Related]
39. Patterns of germline and somatic mutations in 16 genes associated with mismatch repair function or containing tandem repeat sequences.
Chang SC; Lan YT; Lin PC; Yang SH; Lin CH; Liang WY; Chen WS; Jiang JK; Lin JK
Cancer Med; 2020 Jan; 9(2):476-486. PubMed ID: 31769227
[TBL] [Abstract][Full Text] [Related]
40. EMAST is associated with a poor prognosis in microsatellite instable metastatic colorectal cancer.
Venderbosch S; van Lent-van Vliet S; de Haan AF; Ligtenberg MJ; Goossens M; Punt CJ; Koopman M; Nagtegaal ID
PLoS One; 2015; 10(4):e0124538. PubMed ID: 25884216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
